Literature DB >> 21490696

Ranibizumab: a medical treatment that requires surgical administration.

W M Amoaku.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21490696      PMCID： PMC3171254          DOI： 10.1038/eye.2011.3

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  17 in total

1.  High-molecular-weight aggregates in repackaged bevacizumab.

Authors:  Malik Y Kahook; Lu Liu; Philip Ruzycki; Naresh Mandava; John F Carpenter; J Mark Petrash; David A Ammar
Journal:  Retina       Date:  2010-06       Impact factor: 4.256

Review 2.  Evolving guidelines for intravitreous injections.

Authors:  Lloyd P Aiello; Alexander J Brucker; Stanley Chang; Emmett T Cunningham; Donald J D'Amico; Harry W Flynn; Lisa R Grillone; Steve Hutcherson; Jeffrey M Liebmann; Terrence P O'Brien; Ingrid U Scott; Richard F Spaide; Christopher Ta; Michael T Trese
Journal:  Retina       Date:  2004-10       Impact factor: 4.256

Review 3.  Ranibizumab: Phase III clinical trial results.

Authors:  Philip J Rosenfeld; Ryan M Rich; Geeta A Lalwani
Journal:  Ophthalmol Clin North Am       Date:  2006-09

4.  Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials.

Authors:  Donald J D'Amico; H N Masonson; Manju Patel; A P Adamis; E T Cunningham; D R Guyer; B Katz
Journal:  Ophthalmology       Date:  2006-04-27       Impact factor: 12.079

5.  Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

Authors:  David M Brown; Peter K Kaiser; Mark Michels; Gisele Soubrane; Jeffrey S Heier; Robert Y Kim; Judy P Sy; Susan Schneider
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

6.  Ranibizumab for neovascular age-related macular degeneration.

Authors:  Philip J Rosenfeld; David M Brown; Jeffrey S Heier; David S Boyer; Peter K Kaiser; Carol Y Chung; Robert Y Kim
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

Review 7.  The role of vascular endothelial growth factor in angiogenesis.

Authors:  N Ferrara; H P Gerber
Journal:  Acta Haematol       Date:  2001       Impact factor: 2.195

8.  Global data on visual impairment in the year 2002.

Authors:  Serge Resnikoff; Donatella Pascolini; Daniel Etya'ale; Ivo Kocur; Ramachandra Pararajasegaram; Gopal P Pokharel; Silvio P Mariotti
Journal:  Bull World Health Organ       Date:  2004-12-14       Impact factor: 9.408

9.  VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface.

Authors:  Y A Muller; Y Chen; H W Christinger; B Li; B C Cunningham; H B Lowman; A M de Vos
Journal:  Structure       Date:  1998-09-15       Impact factor: 5.006

10.  Age-related macular degeneration and blindness due to neovascular maculopathy.

Authors:  F L Ferris; S L Fine; L Hyman
Journal:  Arch Ophthalmol       Date:  1984-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.